Zurich Cantonal Bank
ANAC

Zurich Cantonal Bank’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Zurich Cantonal Bank’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,070
Closed -$57K – 2622
2016
Q1 		$57K Hold
1,070
– – ﹤0.01% 1384
2015
Q4 		$121K Buy
1,070
+616
+136% +$67.9K ﹤0.01% 1055
2015
Q3 		$53K Buy
454
+250
+123% +$32.7K ﹤0.01% 1070
2015
Q2 		$16K Hold
204
– – ﹤0.01% 1183
2015
Q1 		$12K Buy
+204
New +$8.66K ﹤0.01% 1299

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Zurich Cantonal Bank's ANAC Position: Q2 2016 in Review

Zurich Cantonal Bank sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,070 shares — an estimated $57K sold.

Zurich Cantonal Bank first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $121K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Zurich Cantonal Bank reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,070 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $57K.
  • Zurich Cantonal Bank first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
  • Zurich Cantonal Bank's ANACOR PHARMACEUTICALS INC COM position peaked at $121K in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Zurich Cantonal Bank's 13F filing for Q2 2016, filed 1 Aug 2016.